Strata Critical Medical, Inc.
5.22USD
-0.0900 (-1.69%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.01▲ | $-0.02 | 1 | 0 |
| Next quarter | $0.01▲ | $-0.02 | 0 | 0 |
| Current year | $-0.09▼ | $-0.07 | 1 | 0 |
| Next year | $0▲ | $-0.01 | 1 | 0 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.02 | $-0.12 | -0.10 (-500.0%) |
| 2026-03-31 | $-0.04 | $0.04 | +0.08 (+212.0%) |
| 2025-12-31 | $-0.01 | $-0.06 | -0.05 (-500.0%) |
| 2025-09-30 | $-0.02 | $-0.12 | -0.10 (-500.0%) |
3 ratings from 3 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Craig-Hallum | Initiated | Buy | $8 | Mar 25, 2026 |
| B. Riley Securities | Initiated | Buy | $8 | Mar 25, 2026 |
| Lake Street | Maintained | Buy | $6.5 $7.25 | Sep 17, 2025 |
88 filings from 14 insiders · 14 buy / 7 sell over 6m
Officers and directors of SRTA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| LOVE REGINALD LAMONTEDirector | Sell | 5.1k | $5.75 | $29k | Aug 10, 2026 |
| WIESENTHAL ROBERT SDirector | Grant | 50.2k | — | — | Jul 30, 2026 |
| LOVE REGINALD LAMONTEDirector | Grant | 37.7k | — | — | Jul 30, 2026 |
| PHILIP EDWARD MDirector | Grant | 30.9k | — | — | Jul 30, 2026 |
| HEYBURN WILLIAM AChief Executive Officer | Grant | 360.2k | — | — | Jul 30, 2026 |
| TOMKIEL MELISSA M.Chief Executive Officer | Grant | 415.9k | — | — | Jul 30, 2026 |
| COHEN AMIROfficer | Grant | 69.2k | — | — | Jul 30, 2026 |
| LAUCK ANDREWDirector | Grant | 35.3k | — | — | Jul 30, 2026 |
| WUNSCH SCOTT MOfficer | Grant | 57.2k | — | — | Jul 30, 2026 |
| COOK WILLIAM L IIIDirector | Grant | 44.4k | — | — | Jul 30, 2026 |
| HEYBURN WILLIAM AChief Executive Officer | Sell | 31.7k | $5.87 | $186k | Jun 8, 2026 |
| TOMKIEL MELISSA M.Chief Executive Officer | Sell | 29.7k | $5.87 | $175k | Jun 8, 2026 |
| COHEN AMIROfficer | Sell | 4.7k | $5.87 | $27k | Jun 8, 2026 |
| WUNSCH SCOTT MOfficer | Sell | 5.5k | $5.87 | $33k | Jun 8, 2026 |
| COHEN AMIROfficer | Sell | 50.9k | $5.79 | $299k | May 22, 2026 |
| COHEN AMIROfficer | Sell | 14.3k | $5.79 | $83k | May 11, 2026 |
| HEYBURN WILLIAM AChief Executive Officer | Grant | 545.6k | — | — | Apr 23, 2026 |
| TOMKIEL MELISSA M.Chief Executive Officer | Grant | 630.3k | — | — | Apr 23, 2026 |
| COHEN AMIROfficer | Grant | 83.5k | — | — | Apr 23, 2026 |
| WUNSCH SCOTT MOfficer | Grant | 57.2k | — | — | Apr 23, 2026 |
Analyst Ratings
4 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 4 | 0 | 0 | 0 | Buy2.00 |
| 1 mo ago | 0 | 4 | 0 | 0 | 0 | Buy2.00 |
| 2 mo ago | 0 | 4 | 0 | 0 | 0 | Buy2.00 |